Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study
Introduction: Trastuzumab emtansine (T-DM1) is one of the effective treatment options in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients. In this study, we aimed to find the effect of T-DM1 on survival, its tolerability and prognostic factors of T-DM1 treatment. Mater...
Uloženo v:
| Vydáno v: | Iberoamerican Journal of Medicine |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hospital San Pedro
2022
|
| Témata: | |
| On-line přístup: | https://www.redalyc.org/articulo.oa?id=692072548004 https://www.redalyc.org/journal/6920/692072548004/ https://www.redalyc.org/journal/6920/692072548004/html/ https://www.redalyc.org/journal/6920/692072548004/692072548004.epub https://www.redalyc.org/journal/6920/692072548004/movil https://doi.org/10.53986/ibjm.2022.0033 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|